top of page

BioWorld

  • Writer: Elevate Weekly
    Elevate Weekly
  • Apr 1
  • 1 min read

Bright Uro shines with $23M series A for Glean urodyanmics system

Bright Uro Inc. raised $23 million in a series A fundraising round to support its pursuit of U.S. FDA 510(k) clearance and launch of its Glean urodynamics system. Glean offers catheter-less assessment of the function of the bladder and urethra that uses an inserted pressure sensor instead…

Comments

bottom of page